Amedeo Smart

Free Medical Literature Service

 

Amedeo

Tuberculosis
  Free Subscription

Articles published in
Clin Infect Dis
    October 2026
  1. WOOD RC, Olson AM, Lochner KA, Dragovich RB, et al
    Tongue Swab Mycobacterium tuberculosis Quantitative Polymerase Chain Reaction for Community Screening of Asymptomatic Tuberculosis Versus Clinic-Based Triage of Symptomatic Tuberculosis.
    Clin Infect Dis. 2026 Oct 9:ciag443. doi: 10.1093.
    >> Share

    September 2026

  2. Correction to: The Xpert MTB/RIF Cycle Threshold Value Predicts Mycobacterium tuberculosis Transmission to Close Contacts in a Brazilian Prospective Multicenter Cohort.
    Clin Infect Dis. 2026 Sep 30:ciag589. doi: 10.1093.
    >> Share

  3. SELEMON A, Fernandes ML, Romanowski K, Melnychuk L, et al
    Safety of tuberculosis preventive treatment among people receiving or about to initiate immunosuppressive medications: a systematic review and meta-analysis.
    Clin Infect Dis. 2026 Sep 21:ciag584. doi: 10.1093.
    >> Share

  4. RAJENDRAN P, Pai M
    Non-invasive options for pediatric tuberculosis diagnosis: the search continues.
    Clin Infect Dis. 2026 Sep 18:ciag574. doi: 10.1093.
    >> Share

  5. MCKENNA L, Frick M, Alarcon-Guizado VA, Davies GR, et al
    When are Uncontrolled Trials in TB Scientifically and Ethically Justified: Borrowing Wisdom From Early AIDS Clinical Trials.
    Clin Infect Dis. 2026;83:e399-e403.
    >> Share

    August 2026
  6. ZAZUETA OE, Becerra MC, Galea JT, Calderon RI, et al
    The Impact of Isoniazid Preventive Therapy on Tuberculosis Infection and Disease Progression.
    Clin Infect Dis. 2026 Aug 17:ciag483. doi: 10.1093.
    >> Share


  7. Correction to: The TSwaY Study Network, Diagnostic Yield of Tongue Swab- Compared to Sputum-Based Molecular Testing for Tuberculosis in Four High-Burden Countries.
    Clin Infect Dis. 2026 Aug 4:ciag455. doi: 10.1093.
    >> Share

    July 2026

  8. Correction to: Pregnant Women With Multidrug-Resistant/Rifampicin-Resistant Tuberculosis and the All-Oral 6-Month Regimen: Experiences From a Patient Series in South Africa.
    Clin Infect Dis. 2026 Jul 25:ciag448. doi: 10.1093.
    >> Share

  9. SINHA P, Goffin BD, Karoly M, Kumar N, et al
    Incorporating ambient air pollution as a risk factor for tuberculosis mortality in Delhi, India.
    Clin Infect Dis. 2026 Jul 15:ciag424. doi: 10.1093.
    >> Share

  10. CROSS GB, Walker HN, Hasan T, Berry C, et al
    We Are Underprepared for Bedaquiline Resistance: A Call for Clinical and Programmatic Readiness.
    Clin Infect Dis. 2026;82:e1326-e1332.
    >> Share

  11. SHEN E, Algozhin Y, Trevisi L, LaHood A, et al
    Low Post-Treatment Recurrence After a Shortened All-oral Regimen for Pulmonary Rifampicin- or Multidrug-Resistant Tuberculosis in Individuals without Prior Second-Line Drug Exposure in Kazakhstan.
    Clin Infect Dis. 2026 Jul 1:ciag391. doi: 10.1093.
    >> Share

    June 2026
  12. MOHAN G, Hanrahan CF, Martinez-Amezcua P, Hoffmann CJ, et al
    Multidimensional Poverty and Implementation Reach of Household Contact Tracing for Tuberculosis in South Africa: Analysis of a Randomized Trial.
    Clin Infect Dis. 2026 Jun 17:ciag321. doi: 10.1093.
    >> Share

  13. ROMO M, LaHood A, Mitnick CD, Rich ML, et al
    Comparison of three linezolid management strategies for peripheral neuropathy in multidrug- or rifampicin-resistant tuberculosis treatment: a target trial emulation.
    Clin Infect Dis. 2026 Jun 12:ciag361. doi: 10.1093.
    >> Share

  14. SIDDIQI OK, Jahn B, Rochau U, Walukaga S, et al
    Cost-effectiveness Analysis of Xpert MTB/RIF Ultra for the Diagnosis of HIV-Associated Tuberculous Meningitis.
    Clin Infect Dis. 2026 Jun 9:ciag348. doi: 10.1093.
    >> Share

    May 2026
  15. MA Z, Yu X, Yu Y, Wang Y, et al
    Near-point-of-care diagnosis of tuberculosis with LyocartE MTB Assay: a multicentre diagnostic accuracy study.
    Clin Infect Dis. 2026 May 29:ciag342. doi: 10.1093.
    >> Share

  16. VUYYURU SK, Singh U, Das P, Basant S, et al
    Association of Mycobacterium avium paratuberculosis With Crohn's Disease: A Large Multicenter Study From a Tuberculosis-Endemic Region.
    Clin Infect Dis. 2026;82:841-847.
    >> Share

  17. HUANG CC, Tan Q, Becerra MC, Calderon R, et al
    Impact of Diabetes Mellitus in Tuberculosis (TB) Patients on TB Transmission.
    Clin Infect Dis. 2026;82:829-840.
    >> Share

  18. CHIHOTA V, Waggie Z, Cardenas V, Mngadi K, et al
    Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial.
    Clin Infect Dis. 2026 May 17:ciag315. doi: 10.1093.
    >> Share

  19. CHANG VWL, Li Q, Barnes D, Byrne AL, et al
    Three months of weekly rifapentine and isoniazid versus four months of rifampicin for tuberculosis infection: a randomised controlled trial.
    Clin Infect Dis. 2026 May 15:ciag306. doi: 10.1093.
    >> Share

  20. BARRY SE
    Efficacy Is Not Enough: Delivering Tuberculosis Preventive Therapy in the Real World.
    Clin Infect Dis. 2026 May 12:ciag307. doi: 10.1093.
    >> Share

    April 2026
  21. BHAVARAJU R, Andrade B, Siminski S, Kim S, et al
    A Narrative Review of the Regional Prospective Observational Research in Tuberculosis International Consortium: Sharing Diverse Data and Specimens in the Fight Against Tuberculosis.
    Clin Infect Dis. 2026;82.
    >> Share

  22. GUPTE AN, Boisson-Walsh A, Huaman MA, Bhavaraju R, et al
    Long-term Sequelae of Pulmonary Tuberculosis: A Narrative Review.
    Clin Infect Dis. 2026;82.
    >> Share

  23. ARAUJO-PEREIRA M, Bhavaraju R, Hatherill M, Gupta A, et al
    From Exposure to Disease: Predicting Tuberculosis Progression.
    Clin Infect Dis. 2026;82.
    >> Share

  24. DUARTE BB, Ellner J, Wright AD, Hatherill M, et al
    Asymptomatic Tuberculosis Across the Disease Spectrum: A Scoping Review of Epidemiology, Diagnosis, and Public Health Implications.
    Clin Infect Dis. 2026;82.
    >> Share

  25. ZHAN S, Liu W, Yang L, Chen Z, et al
    Fixed-Dose Rifapentine-Isoniazid (1HP) for Tuberculosis Preventive Treatment in Chinese Adults: A Prospective Real-World Safety and Pharmacokinetic Study.
    Clin Infect Dis. 2026 Apr 13:ciag247. doi: 10.1093.
    >> Share

    March 2026
  26. YANG Y
    When IS900 Positivity is not the Tie-Breaker: Interpreting Mycobacterium avium Subspecies paratuberculosis Signals Across Crohn's Disease and Intestinal Tuberculosis in a Tuberculosis-Endemic Setting.
    Clin Infect Dis. 2026 Mar 27:ciag127. doi: 10.1093.
    >> Share

  27. VISEK C, Dalmat RR, Nalutaaya A, Erisa KC, et al
    Prevalence and Predictors of Tuberculosis in Adults and Adolescents With Sputum Trace Ultra Results in 2 High-Burden Clinical Settings.
    Clin Infect Dis. 2026 Mar 20:ciag019. doi: 10.1093.
    >> Share

  28. KUMAR D SS, Somarkutty N, Prasad D JH, Gautam P, et al
    Role of Low-Dose Infliximab for Inflammatory Complications of Central Nervous System Tuberculosis: A Retrospective Cohort Study.
    Clin Infect Dis. 2026 Mar 20:ciaf573. doi: 10.1093.
    >> Share

  29. VARGAS DA, Fuertes-Bucheli JF, Sanchez-Hidalgo A, Palomares Velosa J, et al
    Diagnostic Accuracy of Molecular Testing on Saliva and Oral Swabs for Pulmonary Tuberculosis.
    Clin Infect Dis. 2026 Mar 12:ciag055. doi: 10.1093.
    >> Share

  30. KOSENKO M, Davtian L, Iakovleva E, Ashurov M, et al
    Shorter Antitubercular Regimens Versus 9 Months of Isoniazid for Latent Tuberculosis in Children: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2026 Mar 10:ciag073. doi: 10.1093.
    >> Share

  31. MOE CA, Luswata RK, Barrameda AJ, Le H, et al
    Diagnostic Yield of Tongue Swab- Compared to Sputum-Based Molecular Testing for Tuberculosis in Four High-Burden Countries.
    Clin Infect Dis. 2026 Mar 10:ciag077. doi: 10.1093.
    >> Share

  32. YANG E, Van Brantegem P, Peloquin CA, Brooks MB, et al
    Pharmacokinetic and pharmacogenomic predictors of hepatotoxicity in the HIRIF trial for drug-susceptible tuberculosis.
    Clin Infect Dis. 2026 Mar 6:ciag141. doi: 10.1093.
    >> Share

    February 2026
  33. APRIANI L, Sidhu H, Korobitsyn A, Ismail N, et al
    Diagnostic Performance of New Commercial IGRAs for Mycobacterium tuberculosis Infection: An updated Systematic Review and Meta-analysis.
    Clin Infect Dis. 2026 Feb 25:ciag102. doi: 10.1093.
    >> Share

  34. CROWDER R, Thangakunam B, Andama A, Christopher DJ, et al
    Diagnostic Accuracy of Tuberculosis Screening Tests in a Prospective Multinational Cohort: Chest Radiography With Computer-Aided Detection, Xpert Tuberculosis Host Response, and C-Reactive Protein.
    Clin Infect Dis. 2026;82:e239-e247.
    >> Share

  35. CHEN R, Shen Y, Liu H, Wang M, et al
    Intrathecal Isoniazid and Dexamethasone Therapy May Improve Outcomes in Patients with Tuberculous Meningitis: A Two-Center Retrospective Cohort Study.
    Clin Infect Dis. 2026 Feb 18:ciag106. doi: 10.1093.
    >> Share

  36. CAMPBELL JI, Brooks MB, Dankovchik J, Giebultowicz S, et al
    Uncovering household tuberculosis infection testing and care patterns using a novel bioinformatics linkage strategy.
    Clin Infect Dis. 2026 Feb 11:ciag079. doi: 10.1093.
    >> Share

  37. KUHLIN J, Stadler JAM, Grint DJ, Court R, et al
    Treatment adherence with an oral nine-month regimen for rifampicin-resistant tuberculosis in South Africa.
    Clin Infect Dis. 2026 Feb 9:ciag069. doi: 10.1093.
    >> Share

  38. WANG Y, Li R, Cai L, Jin L, et al
    Accuracy of rapid quantitative PCR on tongue swabs for pulmonary tuberculosis in sputum-scarce patients: a prospective multicentre diagnostic study.
    Clin Infect Dis. 2026 Feb 9:ciag071. doi: 10.1093.
    >> Share

  39. GRINT DJ, Dhillon J, Butcher PD, Adams J, et al
    Xpert MTB/RIF Cycle Threshold as a Marker of Tuberculosis (TB) Disease Severity: Implications for TB Treatment Stratification.
    Clin Infect Dis. 2026;82:e126-e134.
    >> Share

  40. DE NOOY A, Omar SV, Ockhuisen T, Zwerling A, et al
    Cost-effectiveness of Targeted Next-Generation Sequencing for Tuberculosis Drug-resistance Testing as an Alternative to the Standard of Care in South Africa.
    Clin Infect Dis. 2026;82:e119-e125.
    >> Share

  41. SOLOVYEVA AV, Volchenkov GV, Ponomarenko OI, Kuznezova TA, et al
    Implementing a Program of Comprehensive Tuberculosis Preventive Treatment: Safety, Effectiveness, and Acceptability of Moxifloxacin or Bedaquiline Use for Contacts Exposed to Drug-Resistant Strains.
    Clin Infect Dis. 2026 Feb 3:ciaf701. doi: 10.1093.
    >> Share

    January 2026
  42. MANZOOR F, Rhee C, Baker MA, Klompas M, et al
    Mycobacterium tuberculosis Transmission in Healthcare Settings: A Systematic Review of Frequency, Risk Factors, and Exposure Conditions.
    Clin Infect Dis. 2026 Jan 30:ciag053. doi: 10.1093.
    >> Share

  43. LOVEDAY M, Clarence E, Hlangu S, Singh N, et al
    Pregnant women with MDR/RR-TB and the all-oral 6-month regimen: experiences from a patient series in South Africa.
    Clin Infect Dis. 2026 Jan 22:ciag032. doi: 10.1093.
    >> Share

  44. STARKE S, Thomas K, Jasuja S, Lubelchek R, et al
    Short-Course Tuberculosis Preventive Therapy in a High Migration Setting: Early Experience With 1HP in Cook County, Illinois.
    Clin Infect Dis. 2026 Jan 21:ciaf723. doi: 10.1093.
    >> Share

  45. SWEETSER B, Nguyen H, Dang H, Katumba D, et al
    Evaluating the Cepheid Xpert TB/LTBI research-use-only assay for detection of active and latent Mycobacterium tuberculosis infection.
    Clin Infect Dis. 2026 Jan 21:ciag005. doi: 10.1093.
    >> Share

  46. NIWARD K, Braian C, Svardhagen G, Augustinsson D, et al
    Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine-An Approach for Clinical Management.
    Clin Infect Dis. 2026 Jan 15:ciaf663. doi: 10.1093.
    >> Share

  47. NALUGWA T, Shah KM, Marcelo D, Nakawunde R, et al
    Predicted Preferences for Tuberculosis Point-of-Care Tests among Tuberculosis-Affected Individuals in Five High Burden Countries.
    Clin Infect Dis. 2026 Jan 14:ciag022. doi: 10.1093.
    >> Share


  48. Correction to: Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa.
    Clin Infect Dis. 2026 Jan 9:ciaf711. doi: 10.1093.
    >> Share

    December 2025
  49. OSUALA EC, Nkuhairwe IN, Letsoalo MP, Naidoo K, et al
    Pharmacokinetics of Twice-Daily Tenofovir Alafenamide In Adults with HIV-Associated TB on BIC/FTC/TAF and Rifampicin.
    Clin Infect Dis. 2025 Dec 30:ciaf732. doi: 10.1093.
    >> Share

  50. SALAZAR-AUSTIN N, Cohn S, Nonyane BAS, Mulder C, et al
    Effectiveness of a Home-based Approach to Child Contact Investigation and Tuberculosis Preventive Treatment Management by Community Health Workers in Ethiopia: A Pragmatic Cluster-randomized Trial.
    Clin Infect Dis. 2025;81:e385-e392.
    >> Share

  51. MBULI C, Jean Bosco TF, Nsamenang R, Nestor B, et al
    Diagnostic performance of the Pluslife MiniDock MTB and Molbio MTB Ultima assays to detect tuberculosis from tongue and sputum swabs among outpatients and in active case finding in Cameroon.
    Clin Infect Dis. 2025 Dec 23:ciaf709. doi: 10.1093.
    >> Share

  52. MARINO AM, Arua E, de Vos L, Fiphaza K, et al
    Hidden in Success: Gendered Patterns of Suboptimal Care Engagement Among TB Patients Who "Successfully" Completed Treatment in South Africa.
    Clin Infect Dis. 2025 Dec 19:ciaf714. doi: 10.1093.
    >> Share

  53. CALDERIN JM, Resendiz-Galvan JE, Abdelgawad N, Davis A, et al
    Pharmacokinetics of Dexamethasone in Tuberculous Meningitis.
    Clin Infect Dis. 2025 Dec 18:ciaf642. doi: 10.1093.
    >> Share

  54. MCCREESH N, MacPherson P, Bampi JVB, Engel N, et al
    Reported Tuberculosis Symptoms: An Inadequate Classifier of Disease State.
    Clin Infect Dis. 2025 Dec 10:ciaf611. doi: 10.1093.
    >> Share

  55. DALE KD
    Why we should move away - not towards - symptom-based terminology and policy in tuberculosis.
    Clin Infect Dis. 2025 Dec 5:ciaf667. doi: 10.1093.
    >> Share

    November 2025
  56. NGUYEN HT, Vo LNQ, Codlin AJ, Forse R, et al
    Diagnostic Accuracy of the STANDARD F TB-Feron FIA Assay for Tuberculosis Infection in Vietnam: A Cross-Sectional Study.
    Clin Infect Dis. 2025 Nov 26:ciaf561. doi: 10.1093.
    >> Share

  57. MURRILL MT, Velasquez GE, Szumowski JD, Phillips A, et al
    Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures.
    Clin Infect Dis. 2025 Nov 19:ciaf628. doi: 10.1093.
    >> Share

    October 2025
  58. LOVEDAY M, Hughes J, Mchunu N, Yende-Zuma N, et al
    Maternal, pregnancy and infant outcomes in women treated for multidrug/rifampicin-resistant tuberculosis with novel and repurposed drugs in KwaZulu-Natal, South Africa.
    Clin Infect Dis. 2025 Oct 29:ciaf593. doi: 10.1093.
    >> Share

  59. WIJK M, Denti P, Gausi K, Myers B, et al
    Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment.
    Clin Infect Dis. 2025 Oct 24:ciaf586. doi: 10.1093.
    >> Share

  60. MINGCHAY P, Kawkitinarong K, Torvorapanit P, Ohata PJ, et al
    Effectiveness of Nebulized Bronchodilator - Enhanced Sputum Induction in Thai Patients with Presumed Pulmonary Tuberculosis; A Randomized Controlled Trial; (NeB-TB Trial).
    Clin Infect Dis. 2025 Oct 23:ciaf580. doi: 10.1093.
    >> Share

  61. MULENGA H, Shenje J, Mendelsohn SC, Luabeya AKK, et al
    Asymptomatic Tuberculosis in Children with Household Exposure to Mycobacterium tuberculosis.
    Clin Infect Dis. 2025 Oct 15:ciaf562. doi: 10.1093.
    >> Share

  62. CHEN SC, Lee YT
    Precision Prevention of Tuberculosis in Biologic Therapy: Lessons Beyond Screening Strategies.
    Clin Infect Dis. 2025 Oct 3:ciaf559. doi: 10.1093.
    >> Share

    September 2025
  63. RUIZ-TAGLE C, Seguel R, Villarroel L, Bernales M, et al
    Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial.
    Clin Infect Dis. 2025 Sep 26:ciaf526. doi: 10.1093.
    >> Share

  64. CHEN SC, Chen CC
    Reassessing Adherence Trajectories in Multidrug-Resistant Tuberculosis: Recovery Advantage and Hidden Biases.
    Clin Infect Dis. 2025 Sep 25:ciaf536. doi: 10.1093.
    >> Share

  65. BROOKS MB, Lecca L, Becerra MC, Calderon RI, et al
    The Role of Youths in Within-Household Tuberculosis Transmission: A Household Contact Cohort Study.
    Clin Infect Dis. 2025 Sep 24:ciaf490. doi: 10.1093.
    >> Share

  66. PEREZ-RECIO S, Grijota-Camino MD, Guardiola J, Juanola X, et al
    Prevention of Tuberculosis in Patients Treated With Biological Therapies: Twenty Years' Experience in a Specialised Tuberculosis Clinic in a Low-prevalence Country.
    Clin Infect Dis. 2025 Sep 5:ciaf491. doi: 10.1093.
    >> Share

  67. ARRIAGA MB, Amorim G, Figueiredo MC, Staats C, et al
    Body Mass Index and Incident Tuberculosis in Close Tuberculosis Contacts.
    Clin Infect Dis. 2025 Sep 3:ciaf475. doi: 10.1093.
    >> Share

    August 2025
  68. LAW S, Fulcher I, Ashraf S, Bastard M, et al
    Characterizing treatment adherence trajectories in the endTB multisite cohort of drug-resistant tuberculosis patients: an application of group-based trajectory modelling.
    Clin Infect Dis. 2025 Aug 22:ciaf467. doi: 10.1093.
    >> Share

  69. POORE H, Wambi P, Nkereuwem E, Nakafeero J, et al
    The three-gene Xpert Host Response signature for pediatric tuberculosis screening: A prospective diagnostic accuracy study.
    Clin Infect Dis. 2025 Aug 21:ciaf445. doi: 10.1093.
    >> Share

  70. SINHA P, Bhargava M, Dauphinais MR, Carwile ME, et al
    In-kind Nutritional Supplementation for Persons With Drug-susceptible Tuberculosis and Their Household Contacts Would be Cost-effective for Reducing Tuberculosis Incidence and Mortality in Jharkhand, India: A Modeling Study.
    Clin Infect Dis. 2025 Aug 20:ciaf400. doi: 10.1093.
    >> Share

  71. BISIMWA BC, Kiselinova M, Cuella I, Rigouts L, et al
    Retrospective Cohort Analysis for Identification of Discordant Rifampicin-resistant Xpert MTB/RIF Assay Results in South Kivu, Eastern Democratic Republic of the Congo, a High Burden Tuberculosis Setting.
    Clin Infect Dis. 2025 Aug 12:ciaf451. doi: 10.1093.
    >> Share

  72. CHURCHYARD GJ, Swindells S, Gupta A, Shah NS, et al
    Preventing multidrug resistant tuberculosis: the dawn of a new era.
    Clin Infect Dis. 2025 Aug 7:ciaf426. doi: 10.1093.
    >> Share

  73. CHELI S, Torre A, Schiuma M, Montrasio C, et al
    NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study.
    Clin Infect Dis. 2025;81:145-152.
    >> Share

    July 2025
  74. MURRAY MB, Madden AE, Ofori SK
    Harmonization of Study Design and Reporting for Chronic Pulmonary Aspergillosis in Tuberculosis Patients.
    Clin Infect Dis. 2025 Jul 30:ciaf309. doi: 10.1093.
    >> Share

  75. BEZUIDENHOUT C, Long L, Nichols B, Meyer-Rath G, et al
    Sputum and tongue swab molecular testing for the in-home diagnosis of tuberculosis in unselected household contacts: a cost and cost-effectiveness analysis.
    Clin Infect Dis. 2025 Jul 24:ciaf389. doi: 10.1093.
    >> Share

  76. LIU W, He T, Zhan S, Qin H, et al
    Safety, feasibility and rifapentine plasma concentration in Chinese children with 1 month of daily rifapentine plus isoniazid for tuberculosis infection.
    Clin Infect Dis. 2025 Jul 21:ciaf404. doi: 10.1093.
    >> Share

  77. ROCKMAN L, Abdulgader SM, Minnies S, Palmer Z, et al
    Oral washes and tongue swabs for Xpert MTB/RIF Ultra-based tuberculosis diagnosis in people with and without the ability to make sputum.
    Clin Infect Dis. 2025 Jul 18:ciaf397. doi: 10.1093.
    >> Share

  78. ANDREWS JR, Kendall EA, Cattamanchi A, Denkinger CM, et al
    Projecting the impact and costs of near point-of-care tuberculosis screening assays in community-based active case finding.
    Clin Infect Dis. 2025 Jul 17:ciaf395. doi: 10.1093.
    >> Share

  79. MACLEAN EL, Pham YN, Pham CD, Nguyen BC, et al
    Long-term outcomes among people with multi-drug resistant tuberculosis in Vietnam: a prospective cohort study.
    Clin Infect Dis. 2025 Jul 9:ciaf363. doi: 10.1093.
    >> Share

  80. LI Y, Zhang Y, Song L, Cai C, et al
    A Short, All-Oral Regimen for Pre-Extensively Drug-Resistant Tuberculosis: A Multicenter Open-label Single-arm Study.
    Clin Infect Dis. 2025 Jul 8:ciaf351. doi: 10.1093.
    >> Share

  81. COX SR, Moe AH, Gupte AN, Kadam A, et al
    A point-of-care prediction tool for recurrent tuberculosis.
    Clin Infect Dis. 2025 Jul 8:ciaf353. doi: 10.1093.
    >> Share

    June 2025
  82. TUGUME L, Cresswell FV, Engen NW, Tukundane A, et al
    Prognostic Value of C-Reactive Protein in Adults With Tuberculous Meningitis: A Prospective Cohort Study.
    Clin Infect Dis. 2025 Jun 24:ciaf261. doi: 10.1093.
    >> Share

  83. LU X, Jiang Y, Zhang R, Zhang Y, et al
    Epidemiologic and Bacterial Factors Facilitating Long-Term Transmission of Multidrug-Resistant Tuberculosis in Shanghai, China.
    Clin Infect Dis. 2025 Jun 18:ciaf313. doi: 10.1093.
    >> Share

  84. AGARWAL R, Nyendak M, Chava N, Allam RR, et al
    Long-term protection from TB preventive treatment among people with HIV in a high-burden tuberculosis setting: an observational cohort study from India.
    Clin Infect Dis. 2025 Jun 16:ciaf322. doi: 10.1093.
    >> Share

  85. JAGANATH D, Nabeta P, Nicol MP, Castro R, et al
    Stool processing methods for Xpert Ultra testing in childhood tuberculosis: A prospective, multi-country accuracy study.
    Clin Infect Dis. 2025 Jun 3:ciaf289. doi: 10.1093.
    >> Share

  86. DE JAGER V, Mockeliunas L, You H, Simonsson USH, et al
    A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis.
    Clin Infect Dis. 2025 Jun 2:ciaf276. doi: 10.1093.
    >> Share

    May 2025
  87. PURCHASE SE, Brigden J, Seddon JA, Martinson NA, et al
    Risk of tuberculosis infection in young children exposed to multidrug-resistant tuberculosis in the TB-CHAMP multi-site randomised controlled trial.
    Clin Infect Dis. 2025 May 29:ciaf284. doi: 10.1093.
    >> Share

  88. BONGOMIN F, Denning DW
    Pulmonary Tuberculosis Associated Chronic Pulmonary Aspergillosis: Urgent Need to Standardize Reporting of Prevalence Studies.
    Clin Infect Dis. 2025 May 28:ciaf279. doi: 10.1093.
    >> Share


  89. Correction to: Serial Mass Screening for Tuberculosis Among Incarcerated Persons in Brazil.
    Clin Infect Dis. 2025 May 21:ciaf223. doi: 10.1093.
    >> Share

  90. REGAN JJ, Wang Z, Phares CR
    The Effect of Live-Virus Vaccines on Tests for Tuberculosis Infection During the US Immigration Medical Examination: Are Vaccines Causing False-Negative Results?
    Clin Infect Dis. 2025 May 15:ciaf129. doi: 10.1093.
    >> Share

  91. STADLER JAM, Kuhlin JJ, Molloy SF, Mtwa NN, et al
    Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa.
    Clin Infect Dis. 2025 May 9:ciaf112. doi: 10.1093.
    >> Share

  92. CHIANG SS, Campbell JR, Pelissari DM, de Oliveira MCB, et al
    The Impact of Pregnancy on Tuberculosis Treatment Outcomes: An Analysis of Brazilian National Surveillance Data 2016-2022.
    Clin Infect Dis. 2025 May 6:ciaf233. doi: 10.1093.
    >> Share

    April 2025
  93. LARSSON L, Calderwood CJ, Marambire ET, Held K, et al
    Body mass index trajectories and association with tuberculosis risk in a cohort of household contacts in Southern Africa.
    Clin Infect Dis. 2025 Apr 28:ciaf222. doi: 10.1093.
    >> Share

  94. DAHL VN, Pedersen OS, Butova T, Kuzhko M, et al
    Effectiveness of the BPaL(M) Regimen for Drug-Resistant Tuberculosis in Ukraine under Programmatic Conditions.
    Clin Infect Dis. 2025 Apr 25:ciaf214. doi: 10.1093.
    >> Share

  95. KIM S, Pelissari DM, Harada LO, Sanchez M, et al
    Long-term mortality trends among individuals with tuberculosis: a retrospective cohort study of individuals diagnosed with tuberculosis in Brazil.
    Clin Infect Dis. 2025 Apr 18:ciaf206. doi: 10.1093.
    >> Share

  96. SUTHERLAND JS, van der Spuy GD, Shaw JA, Richardson T, et al
    Performance of 2 Finger-Stick Blood Tests to Triage Adults With Symptoms of Pulmonary Tuberculosis: A Prospective Multisite Diagnostic Accuracy Study.
    Clin Infect Dis. 2025 Apr 16:ciaf105. doi: 10.1093.
    >> Share

  97. MONTEPIEDRA G, Aaron L, Theron G, McCarthy K, et al
    Hepatotoxicity Among People Living with HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics.
    Clin Infect Dis. 2025 Apr 16:ciaf198. doi: 10.1093.
    >> Share


  98. Correction to: Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study.
    Clin Infect Dis. 2025 Apr 4:ciaf174. doi: 10.1093.
    >> Share

  99. STEAD D, Wasserman S, Steenkamp E, Parrish A, et al
    Comparative Performance of Urine Lipoarabinomannan and Urine Xpert MTB/RIF Ultra for Diagnosing Tuberculosis in Adult Inpatients With Human Immunodeficiency Virus in East London, South Africa.
    Clin Infect Dis. 2025 Apr 2:ciaf080. doi: 10.1093.
    >> Share

    March 2025
  100. BARTL L, Zeeb M, Kalin M, Loosli T, et al
    Machine Learning-Based Prediction of Active Tuberculosis in People with HIV using Clinical Data.
    Clin Infect Dis. 2025 Mar 25:ciaf149. doi: 10.1093.
    >> Share

  101. ADZEMOVIC T, Nalintya E, Fieberg A, Mande E, et al
    Diagnostic Accuracy of the Updated FujiLAM II Assay to Detect Tuberculosis in Outpatients With Advanced HIV Disease.
    Clin Infect Dis. 2025 Mar 25:ciaf079. doi: 10.1093.
    >> Share

  102. PRODANUK M, Silverberg SL, Piche-Renaud PP, Farrar DS, et al
    Adverse events of first-line therapy for pediatric tuberculosis: A systematic review and meta-analysis.
    Clin Infect Dis. 2025 Mar 24:ciaf152. doi: 10.1093.
    >> Share

  103. CUELLA-MARTIN I, Hakizayezu F, Ahmed A, Runyambo D, et al
    Paucibacillary tuberculosis drives the low positive predictive value of Xpert MTB/RIF Ultra for rifampicin resistance detection in low-prevalence settings.
    Clin Infect Dis. 2025 Mar 22:ciaf132. doi: 10.1093.
    >> Share

  104. MADDEN A, Ofori SK, Budu M, Sisay E, et al
    A systematic review of chronic pulmonary aspergillosis among patients treated for pulmonary tuberculosis.
    Clin Infect Dis. 2025 Mar 21:ciaf150. doi: 10.1093.
    >> Share

  105. SODEKE O, Shah NS, Pals S, Riabokon S, et al
    Lower Tuberculosis Incidence Among People With Human Immunodeficiency Virus Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-Resistant Tuberculosis Setting: A Retrospective Cohort Study.
    Clin Infect Dis. 2025 Mar 18:ciaf069. doi: 10.1093.
    >> Share

  106. SINGLA R, Khan S, Silsarma A, Chavan V, et al
    Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study.
    Clin Infect Dis. 2025 Mar 13:ciaf068. doi: 10.1093.
    >> Share

    February 2025
  107. JASWAL MR, Martinez L, Brooks M, Farooq S, et al
    Tuberculosis preventive treatment for household contacts at health facility and community settings in Pakistan.
    Clin Infect Dis. 2025 Feb 27:ciaf088. doi: 10.1093.
    >> Share

  108. SWARTWOOD NA, Cohen T, Marks SM, Hill AN, et al
    Effects of the COVID-19 pandemic on TB outcomes in the United States: a Bayesian analysis.
    Clin Infect Dis. 2025 Feb 27:ciaf092. doi: 10.1093.
    >> Share

  109. TZELIOS CA, Malatesta S, Carney T, White LF, et al
    Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis.
    Clin Infect Dis. 2025 Feb 20:ciae642. doi: 10.1093.
    >> Share

  110. SINHA A, Klebe R, Rekart ML, Alvarez JL, et al
    The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)-Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings-A Prospective Cohort Study in Belarus and Uzbekistan.
    Clin Infect Dis. 2025 Feb 18:ciaf035. doi: 10.1093.
    >> Share

  111. MUNSIFF SS
    American Thoracic Society/Centers for Disease Control and Prevention/European Respiratory Society/Infectious Diseases Society of America (ATS/CDC/ERS/IDSA) Updated guideline on the treatment of tuberculosis.
    Clin Infect Dis. 2025 Feb 14:ciaf066. doi: 10.1093.
    >> Share

    January 2025
  112. MARANCHICK N, Peloquin CA, Haley CA
    Linezolid Dosing and Pharmacokinetics in North American Patients with Tuberculosis.
    Clin Infect Dis. 2025 Jan 21:ciaf027. doi: 10.1093.
    >> Share

  113. ESPINOSA-PEREIRO J, Aguiar A, Nara E, Medina A, et al
    Safety, Efficacy and Pharmacokinetics of daily optimised doses of Rifampicin for the Treatment of Tuberculosis: A Systematic Review and Bayesian Network Meta-Analysis.
    Clin Infect Dis. 2025 Jan 10:ciaf003. doi: 10.1093.
    >> Share

  114. ARBIV OA, Holmes T, Kim MJ, Yan M, et al
    Safety of Triple-Dose Rifampin in Tuberculosis Treatment: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2025 Jan 9:ciaf004. doi: 10.1093.
    >> Share

    December 2024
  115. MACPHERSON L, Kik SV, Quartagno M, Lakay F, et al
    Diagnostic Accuracy of Chest X-ray Computer-Aided Detection Software for Detection of Prevalent and Incident Tuberculosis in Household Contacts.
    Clin Infect Dis. 2024 Dec 18:ciae528. doi: 10.1093.
    >> Share

  116. AUMA E, Alberts R, Derendinger B, Venter R, et al
    Diagnostic accuracy of LiquidArray MTB-XDR VER1.0 for the detection of Mycobacterium tuberculosis complex, fluoroquinolone, amikacin, ethambutol, and linezolid susceptibility.
    Clin Infect Dis. 2024 Dec 12:ciae614. doi: 10.1093.
    >> Share

  117. KHAN U, Rich M, Franke M, Lachenal N, et al
    The Frequency and Incidence of QT Prolongation with Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country MDR/RR-TB Cohort.
    Clin Infect Dis. 2024 Dec 10:ciae601. doi: 10.1093.
    >> Share

  118. ZHU Y, Forsman LD, Chen C, Zhang H, et al
    Reply to He et al: Established Association Between Glycemic Control and Anti-Tuberculosis Drug Exposures After Controlling Confounding Effects.
    Clin Infect Dis. 2024 Dec 9:ciae533. doi: 10.1093.
    >> Share

  119. CHEN J, Xie X, Zhang A, He Y, et al
    Is There a Genuine Correlation Between Blood Glucose Control and Anti-tuberculosis Drug Concentrations, or Is it Merely an Illusion?
    Clin Infect Dis. 2024 Dec 9:ciae532. doi: 10.1093.
    >> Share

    November 2024
  120. PUYAT JH, Brode SK, Shulha H, Romanowski K, et al
    Predicting risk of tuberculosis disease in people migrating to a low-TB incidence country: development and validation of a multivariable dynamic risk prediction model using health administrative data.
    Clin Infect Dis. 2024 Nov 20:ciae561. doi: 10.1093.
    >> Share

  121. ROSEN LV, Thielking AM, Dugdale CM, Montepiedra G, et al
    Tuberculosis Preventive Treatment for Pregnant People With Human Immunodeficiency Virus in South Africa: A Modeling Analysis of Clinical Benefits and Risks.
    Clin Infect Dis. 2024 Nov 15:ciae508. doi: 10.1093.
    >> Share

  122. FERRAN E, Chan C, Sheikh N, Dedicoat M, et al
    Population-level frequency of fluoroquinolone resistance by whole-genome sequencing drug predictions in Mycobacterium tuberculosis complex isolates in England from 2017-2023.
    Clin Infect Dis. 2024 Nov 13:ciae560. doi: 10.1093.
    >> Share

  123. PU J, Wu S, He JQ
    Efficacy and Safety of Systematic Corticosteroids treatment among HIV-Positive Patients with Tuberculosis: a systematic review and meta-analysis of randomized controlled trials.
    Clin Infect Dis. 2024 Nov 11:ciae563. doi: 10.1093.
    >> Share

  124. CRITCHLEY JA, Limb ES, Khakharia A, Carey IM, et al
    Tuberculosis and increased incidence of cardiovascular disease: Cohort study using US and UK health records.
    Clin Infect Dis. 2024 Nov 4:ciae538. doi: 10.1093.
    >> Share

    October 2024
  125. BROOKS JT, Solans BP, Beranger A, Schaaf HS, et al
    Linezolid Pharmacokinetic-Anemia Modeling in Children with Rifampicin-Resistant Tuberculosis.
    Clin Infect Dis. 2024 Oct 18:ciae497. doi: 10.1093.
    >> Share

  126. NATHAVITHARANA RR, Pearl A, Biewer A, Young L, et al
    Effects of respiratory isolation for tuberculosis to reduce community-based transmission: a systematic review.
    Clin Infect Dis. 2024 Oct 14:ciae496. doi: 10.1093.
    >> Share

  127. VIRDEE AK, Knudtzen FC, Llibre JM, Omland LH, et al
    Risk of tuberculosis after achieving HIV virological suppression on antiretroviral therapy: a Danish nationwide prospective cohort study.
    Clin Infect Dis. 2024 Oct 8:ciae499. doi: 10.1093.
    >> Share

    September 2024
  128. SEIFERT M, Catanzaro DG, Gracia M, Hillery N, et al
    Prospective exploratory evaluation of Cepheid Xpert Mycobacterium tuberculosis host response cartridge: a focus on adolescents and young adults.
    Clin Infect Dis. 2024 Sep 5:ciae461. doi: 10.1093.
    >> Share

    August 2024
  129. PADMAPRIYADARSINI C, Oswal VS, Jain CD, Mariappan MV, et al
    Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial.
    Clin Infect Dis. 2024 Aug 28:ciae388. doi: 10.1093.
    >> Share

  130. BOSMAN S, Ayakaka I, Muhairwe J, Kamele M, et al
    Evaluation of C-Reactive Protein and Computer-Aided Analysis of Chest X-rays as Tuberculosis Triage Tests at Health Facilities in Lesotho and South Africa.
    Clin Infect Dis. 2024 Aug 27:ciae378. doi: 10.1093.
    >> Share

    July 2024
  131. JARRETT BA, Shearer K, Motlhaoleng K, Chon S, et al
    Comparison of QuantiFERON Gold In-Tube Versus Tuberculin Skin Tests on the Initiation of Tuberculosis Preventive Therapy Among Patients Newly Diagnosed With Human Immunodeficiency Virus in the North West Province of South Africa (the Teko Study): A Cl
    Clin Infect Dis. 2024 Jul 22:ciae268. doi: 10.1093.
    >> Share

  132. PRAKASH BABU S, Ezhumalai K, Raghupathy K, Karoly M, et al
    Factors associated with unfavourable treatment outcomes among persons with Pulmonary Tuberculosis: a multicentric prospective cohort study from India.
    Clin Infect Dis. 2024 Jul 11:ciae367. doi: 10.1093.
    >> Share

  133. WANG MS, Li-Hunnam J, Chen YL, Gilmour B, et al
    Conversion or reversion of interferon gamma release assays for Mycobacterium tuberculosis infection: a systematic review and meta-analysis.
    Clin Infect Dis. 2024 Jul 2:ciae357. doi: 10.1093.
    >> Share

    June 2024
  134. ZHU Y, Forsman LD, Chen C, Zhang H, et al
    Drug exposure and treatment outcomes in patients with multidrug resistant tuberculosis and diabetes mellitus: A multicenter prospective cohort study from China.
    Clin Infect Dis. 2024 Jun 24:ciae329. doi: 10.1093.
    >> Share

  135. RICHTERMAN A, Saintilien E, St-Cyr M, Claudia Gracia L, et al
    Food Insecurity at Tuberculosis Treatment Initiation Is Associated With Clinical Outcomes in Rural Haiti: A Prospective Cohort Study.
    Clin Infect Dis. 2024 Jun 18:ciae252. doi: 10.1093.
    >> Share

  136. RASHITOV M, Franke M, Trevisi L, Bekbolatova G, et al
    Safety and effectiveness of three novel all-oral shortened regimens for rifampicin- or multidrug-resistant tuberculosis in Kazakhstan.
    Clin Infect Dis. 2024 Jun 4:ciae305. doi: 10.1093.
    >> Share

  137. ABBOTT R, Landsiedel K, Atukunda M, Puryear SB, et al
    Incident Tuberculosis Infection is Associated with Alcohol use in Adults in Rural Uganda.
    Clin Infect Dis. 2024 Jun 2:ciae304. doi: 10.1093.
    >> Share

    May 2024
  138. BURKE RM, Nyirenda SK, Mtenga T, Twabi HH, et al
    Enhanced tuberculosis diagnosis with computer-aided chest X-ray and urine LAM in adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial.
    Clin Infect Dis. 2024 May 15:ciae273. doi: 10.1093.
    >> Share

  139. SHAH NS, Kityo C, Hughes MD, McCarthy C, et al
    Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.
    Clin Infect Dis. 2024 May 13:ciae269. doi: 10.1093.
    >> Share

    April 2024
  140. SINHA P, Ezhumalai K, Du X, Ponnuraja C, et al
    Undernourished Household Contacts Are at Increased Risk of Tuberculosis (TB) Disease, but not TB Infection- a Multicenter Prospective Cohort Analysis.
    Clin Infect Dis. 2024 Apr 23:ciae149. doi: 10.1093.
    >> Share

  141. FARHAT MR, Jacobson KR
    For Tuberculosis, Not "To Screen or Not to Screen?" but "Who?" and "How?".
    Clin Infect Dis. 2024 Apr 18:ciae058. doi: 10.1093.
    >> Share

  142. GOSWAMI N, Reed C
    Duration of Effective Tuberculosis Treatment, not Acid-Fast Bacilli (AFB) Smear Status, as the Determinant for Deisolation in Community Settings.
    Clin Infect Dis. 2024 Apr 18:ciae198. doi: 10.1093.
    >> Share

  143. SHAH M, Dansky Z, Nathavitharana R, Behm H, et al
    NTCA Guidelines for Respiratory Isolation and Restrictions to Reduce Transmission of Pulmonary Tuberculosis in Community Settings.
    Clin Infect Dis. 2024 Apr 18:ciae199. doi: 10.1093.
    >> Share

  144. MARINER-LLICER C, Saavedra Cervera B, Mambuque E, Gomes N, et al
    Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique.
    Clin Infect Dis. 2024;78:842-845.
    >> Share

  145. MIKIASHVILI L, Kempker RR, Chakhaia TS, Bablishvili N, et al
    Impact of Prior Tuberculosis Treatment With New/Companion Drugs on Clinical Outcomes in Patients Receiving Concomitant Bedaquiline and Delamanid for Multidrug- and Rifampicin-Resistant Tuberculosis.
    Clin Infect Dis. 2024;78:1043-1052.
    >> Share

  146. CHABALA C, Wobudeya E, van der Zalm MM, Kapasa M, et al
    Clinical outcomes in children living with HIV treated for non-severe tuberculosis in the SHINE Trial.
    Clin Infect Dis. 2024 Apr 9:ciae193. doi: 10.1093.
    >> Share

  147. RODRIGUEZ-MOLINO P, Tebruegge M, Noguera-Julian A, Neth O, et al
    Tuberculosis disease in immunocompromised children and adolescents: a pTBnet multi-centre case-control study.
    Clin Infect Dis. 2024 Apr 3:ciae158. doi: 10.1093.
    >> Share

  148. PODANY AT, Cramer Y, Imperial M, Rosenkranz SL, et al
    Twice-Daily Dolutegravir Based Antiretroviral Therapy with One Month of Daily Rifapentine and Isoniazid (1HP) for TB Prevention.
    Clin Infect Dis. 2024 Apr 3:ciae183. doi: 10.1093.
    >> Share

    March 2024
  149. BERTUMEN JB, Pascopella L, Han E, Glenn-Finer R, et al
    Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B Infection-California, 2016-2020.
    Clin Infect Dis. 2024 Mar 26:ciae169. doi: 10.1093.
    >> Share

  150. MORGAN H, Ndjeka N, Hasan T, Gegia M, et al
    Treatment of multidrug-resistant or rifampicin-resistant tuberculosis with an all-oral 9-month regimen containing linezolid or ethionamide in South Africa: A retrospective cohort study.
    Clin Infect Dis. 2024 Mar 25:ciae145. doi: 10.1093.
    >> Share

  151. SUNSTRUM J, Power LE, Fligiel HM, Lauter C, et al
    Human Disease due to Mycobacterium bovis Linked to Free-Ranging Deer in Michigan.
    Clin Infect Dis. 2024;78:637-645.
    >> Share

  152. KRISHNAN S, Chaisson RE
    US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
    Clin Infect Dis. 2024;78:514-517.
    >> Share

  153. NGO HX, Xu AY, Velasquez GE, Zhang N, et al
    Pharmacokinetic-Pharmacodynamic Evidence from a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
    Clin Infect Dis. 2024 Mar 11:ciae119. doi: 10.1093.
    >> Share

    February 2024
  154. CROCKER-BUQUE T, Lachenal N, Narasimooloo C, Abdrasuliev T, et al
    Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL.
    Clin Infect Dis. 2024 Feb 29:ciad767. doi: 10.1093.
    >> Share

  155. TEIXEIRA LAA, Santos B, Correia MG, Valiquette C, et al
    Long-term protective effect of tuberculosis preventive therapy in a medium/high TB incidence setting.
    Clin Infect Dis. 2024 Feb 26:ciae101. doi: 10.1093.
    >> Share

  156. WHITE YN, Solans BP, Denti P, van der Laan LE, et al
    Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis.
    Clin Infect Dis. 2024 Feb 10:ciae024. doi: 10.1093.
    >> Share

  157. PIVETTA DE ARAUJO RC, Martinez L, da Silva Santos A, Ferreira Lemos E, et al
    Serial Mass Screening for Tuberculosis among Incarcerated Persons in Brazil.
    Clin Infect Dis. 2024 Feb 7:ciae055. doi: 10.1093.
    >> Share

  158. STEADMAN A, Andama A, Ball A, Mukwatamundu J, et al
    New manual qPCR assay validated on tongue swabs collected and processed in Uganda shows sensitivity that rivals sputum-based molecular TB diagnostics.
    Clin Infect Dis. 2024 Feb 2:ciae041. doi: 10.1093.
    >> Share

    January 2024
  159. MARQUEZ C, Atukunda M, Nugent J, Charlebois ED, et al
    Community-Wide Universal Human Immunodeficiency Virus (HIV) Test and Treat Intervention Reduces Tuberculosis Transmission in Rural Uganda: A Cluster-Randomized Trial.
    Clin Infect Dis. 2024 Jan 16:ciad776. doi: 10.1093.
    >> Share

  160. KU JH, Fischer H, Qian LX, Li K, et al
    Latent tuberculosis infection testing practices in a large U.S. integrated healthcare system.
    Clin Infect Dis. 2024 Jan 11:ciae015. doi: 10.1093.
    >> Share

  161. GARCIA LS, Costa AG, Araujo-Pereira M, Spener-Gomes R, et al
    The Xpert(R) MTB/RIF cycle threshold value predicts M. tuberculosis transmission to close contacts in a Brazilian prospective multicenter cohort.
    Clin Infect Dis. 2024 Jan 3:ciad794. doi: 10.1093.
    >> Share

  162. LINDE L, Brooks MB, Martinez L
    Beyond Diagnosis: Xpert Cycle Threshold Values as Predictors of Tuberculosis Transmission.
    Clin Infect Dis. 2024 Jan 3:ciad791. doi: 10.1093.
    >> Share

    December 2023
  163. LIN KY, Sun HY, Yang CJ, Lu PL, et al
    Treatment responses to integrase strand-transfer inhibitor-containing antiretroviral regimens in combination with short-course rifapentine-based regimens for latent tuberculosis infection among people with HIV.
    Clin Infect Dis. 2023 Dec 5:ciad730. doi: 10.1093.
    >> Share

    November 2023
  164. SCHWALB A, Kayumba K, Houben RMGJ, Bothamley GH, et al
    Recent travel and tuberculosis in migrants: data from a low incidence country.
    Clin Infect Dis. 2023 Nov 6:ciad672. doi: 10.1093.
    >> Share

  165. LIU X, Xia L, Wang X, Huang Z, et al
    Treatment Outcomes in Multidrug-Resistant Tuberculosis During Pregnancy.
    Clin Infect Dis. 2023 Nov 1:ciad594. doi: 10.1093.
    >> Share

    October 2023
  166. BROWN TS, Tang L, Omar SV, Joseph L, et al
    Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis.
    Clin Infect Dis. 2023 Oct 24:ciad596. doi: 10.1093.
    >> Share

  167. HASAN T, Medcalf E, Nyang'wa BT, Egizi E, et al
    The safety and tolerability of linezolid in novel short-course regimens containing bedaquiline, pretomanid and linezolid to treat rifampicin-resistant tuberculosis: an individual patient data meta-analysis.
    Clin Infect Dis. 2023 Oct 24:ciad653. doi: 10.1093.
    >> Share

  168. KHAN AR, Tirlangi PK, Wig N, Soneja M, et al
    Immortal Time Bias for Infliximab in Central Nervous System Tuberculosis.
    Clin Infect Dis. 2023 Oct 13:ciad590. doi: 10.1093.
    >> Share

  169. SUNG J, Nantale M, Nalutaaya A, Biche P, et al
    Evidence for tuberculosis in individuals with Xpert Ultra "trace" sputum during screening of high-burden communities.
    Clin Infect Dis. 2023 Oct 3:ciad595. doi: 10.1093.
    >> Share

    September 2023
  170. SAUER SM, Mitnick CD, Khan U, Hewison C, et al
    Estimating post-treatment recurrence after multidrug-resistant tuberculosis treatment among patients with and without HIV: the impact of assumptions about death and missing follow-up.
    Clin Infect Dis. 2023 Sep 29:ciad589. doi: 10.1093.
    >> Share

  171. GUPTA A, Hughes MD, Cruz JL, Avihingsanon A, et al
    Adverse Pregnancy Outcomes among HIV-infected Women Taking Isoniazid Preventive Therapy During the First Trimester.
    Clin Infect Dis. 2023 Sep 28:ciad583. doi: 10.1093.
    >> Share

  172. KASAIE P, Pennington J, Gupta A, Dowdy DW, et al
    The impact of preventive treatment for multidrug- and rifampin-resistant tuberculosis exceeds trial-based estimates.
    Clin Infect Dis. 2023 Sep 19:ciad557. doi: 10.1093.
    >> Share

  173. BOAST A, How JA, Lau C, Sett A, et al
    Pre-XDR congenital tuberculosis in an extremely premature baby.
    Clin Infect Dis. 2023 Sep 8:ciad540. doi: 10.1093.
    >> Share

    August 2023
  174. BRUMMER LE, Thompson RR, Malhotra A, Shrestha S, et al
    Cost effectiveness of low-complexity screening tests in community-based case-finding for tuberculosis.
    Clin Infect Dis. 2023 Aug 25:ciad501. doi: 10.1093.
    >> Share

  175. LOTIA FARRUKH I, Lachenal N, Adenov MM, Ahmed S, et al
    Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs.
    Clin Infect Dis. 2023 Aug 22:ciad445. doi: 10.1093.
    >> Share

  176. SULIMAN S, Jaganath D, DiNardo A
    Predicting Pediatric Tuberculosis: The Need for Age-Specific Host Biosignatures.
    Clin Infect Dis. 2023;77:450-452.
    >> Share

  177. WALLES J, Winqvist N, Hansson SR, Sturegard E, et al
    Pregnancy outcomes in women screened for tuberculosis infection in Swedish antenatal care.
    Clin Infect Dis. 2023 Aug 12:ciad465. doi: 10.1093.
    >> Share

  178. BROUGH J, Martinez L, Hatherill M, Zar HJ, et al
    Public health impact and cost-effectiveness of screening for active tuberculosis disease or infection among children in South Africa.
    Clin Infect Dis. 2023 Aug 5:ciad449. doi: 10.1093.
    >> Share

    July 2023
  179. HU Z, Liu K, Zhou M, Jiang X, et al
    Mass tuberculosis screening among the elderly: A population-based study in a well-confined rural county in eastern China.
    Clin Infect Dis. 2023 Jul 28:ciad438. doi: 10.1093.
    >> Share

  180. WINGFIELD T
    Ending tuberculosis in older people: new strategies for an age-old disease.
    Clin Infect Dis. 2023 Jul 28:ciad439. doi: 10.1093.
    >> Share

  181. ACUNA-VILLAORDUNA C, Fennelly KP, Jones-Lopez EC
    Aerosol Sampling Outperforms Sputum to Predict Mycobacterium tuberculosis Transmission.
    Clin Infect Dis. 2023 Jul 18:ciad372. doi: 10.1093.
    >> Share

  182. S AM, Gautam P, D SSK, Mannam P, et al
    Effectiveness of adjunctive high dose infliximab therapy to improve disability free survival among patients with severe CNS tuberculosis: a matched retrospective cohort study.
    Clin Infect Dis. 2023 Jul 5:ciad401. doi: 10.1093.
    >> Share

    June 2023
  183. MOON SM, Choi H, Kim SH, Kang HK, et al
    Increased lung cancer risk and associated risk factors in tuberculosis survivors: A Korean population-based study.
    Clin Infect Dis. 2023 Jun 22:ciad373. doi: 10.1093.
    >> Share

  184. LUCZYNSKI P, Holmes T, Romanowski K, Arbiv OA, et al
    Risk of tuberculosis disease in people with chronic kidney disease without kidney failure: A systematic review and meta-analysis.
    Clin Infect Dis. 2023 Jun 13:ciad364. doi: 10.1093.
    >> Share

  185. IWASE SC, Edlefsen PT, Bhebhe L, Motsumi K, et al
    T-SPOT.TB reactivity in Southern African children with and without in utero HIV exposure.
    Clin Infect Dis. 2023 Jun 9:ciad356. doi: 10.1093.
    >> Share

  186. SOLANS BP, Imperial MZ, Olugbosi M, Savic RM, et al
    Analysis of Dynamic Efficacy Endpoints of the Nix-TB Trial.
    Clin Infect Dis. 2023;76:1903-1910.
    >> Share

    May 2023
  187. ZEEB M, Tepekule B, Kusejko K, Reiber C, et al
    Understanding the decline of incident, active tuberculosis in people with HIV in Switzerland.
    Clin Infect Dis. 2023 May 31:ciad330. doi: 10.1093.
    >> Share

  188. HALEY CA, Schechter MC, Ashkin D, Peloquin CA, et al
    Implementation of BPaL in the United States: Experience using a novel all-oral treatment regimen for treatment of rifampin-resistant or rifampin-intolerant TB disease.
    Clin Infect Dis. 2023 May 30:ciad312. doi: 10.1093.
    >> Share

  189. AHSBERG J, Puplampu P, Kwashie A, Commey JO, et al
    Point-of-care urine LAM testing to guide tuberculosis treatment among severely ill in-patients with HIV in real-world practice: a multi-center stepped wedge cluster-randomized trial from Ghana.
    Clin Infect Dis. 2023 May 26:ciad316. doi: 10.1093.
    >> Share

  190. KRISHNAN S, Wu X, Kim S, McIntire K, et al
    One-year incidence of tuberculosis infection and disease among household contacts of rifampin- and multi-drug resistant tuberculosis.
    Clin Infect Dis. 2023 May 25:ciad301. doi: 10.1093.
    >> Share

  191. ROMANOWSKI K, Law MR, Karim ME, Campbell JR, et al
    Healthcare utilization after respiratory tuberculosis: a controlled interrupted time series analysis.
    Clin Infect Dis. 2023 May 9:ciad290. doi: 10.1093.
    >> Share

  192. BOBAK CA, Botha M, Workman L, Hill JE, et al
    Gene expression in cord blood and tuberculosis in early childhood: A nested case-control study in a South African birth cohort.
    Clin Infect Dis. 2023 May 5:ciad268. doi: 10.1093.
    >> Share

  193. TIMIRE C, Pedrazzoli D, Boccia D, Houben RM, et al
    Use of a sustainable livelihood framework-based measure to estimate socioeconomic impact of tuberculosis on house-holds.
    Clin Infect Dis. 2023 May 3:ciad273. doi: 10.1093.
    >> Share

  194. LOUIE JK, Keh C
    Latent Tuberculosis Infection Treatment: Still a Long Road Ahead.
    Clin Infect Dis. 2023 May 1:ciad251. doi: 10.1093.
    >> Share

  195. MELNYCHUK L, Perlman-Arrow S, Bastos M, Menzies D, et al
    A Systematic Review and Meta-Analysis of Tuberculous Preventative Therapy Adverse Events.
    Clin Infect Dis. 2023 May 1:ciad246. doi: 10.1093.
    >> Share

    April 2023
  196. BURKE RM, Nliwasa M, Dodd PJ, Feasey HR, et al
    Impact of community-wide tuberculosis active case finding and HIV testing on tuberculosis trends in Malawi.
    Clin Infect Dis. 2023 Apr 26:ciad238. doi: 10.1093.
    >> Share

  197. CHAISSON LH
    Finding tuberculosis: More evidence for community-wide systematic screening.
    Clin Infect Dis. 2023 Apr 26:ciad232. doi: 10.1093.
    >> Share

  198. HUSSAIN H, Jaswal M, Farooq S, Safdar N, et al
    Scale up of rifapentine-isoniazid (3HP) for tuberculosis prevention amongst household contacts in two urban centers: An effectiveness assessment.
    Clin Infect Dis. 2023 Apr 21:ciad245. doi: 10.1093.
    >> Share

  199. SABET N, Omar T, Milovanovic M, Magajane T, et al
    Undiagnosed pulmonary TB and COVID in adults dying at home in a high TB burden setting, before and during pandemic COVID-19: an autopsy study.
    Clin Infect Dis. 2023 Apr 12:ciad212. doi: 10.1093.
    >> Share

    March 2023
  200. UPTON CM, Wiesner L, Dooley KE, Maartens G, et al
    Cerebrospinal Fluid and Tuberculosis Meningitis.
    Clin Infect Dis. 2023 Mar 29:ciad186. doi: 10.1093.
    >> Share

  201. ALLARD-GRAY A, Boakye I, Camara A, Eisenbeis L, et al
    Factors Associated with Discontinuation of Tuberculosis Preventive Treatment: Post-Hoc Analysis of Two Randomized Controlled Trials.
    Clin Infect Dis. 2023 Mar 23:ciad164. doi: 10.1093.
    >> Share

  202. BONNET M, Gabillard D, Domoua S, Muzoora C, et al
    High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF(R) for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV.
    Clin Infect Dis. 2023 Mar 8:ciad125. doi: 10.1093.
    >> Share

  203. LIU Q, You N, Wen J, Wang J, et al
    Yield and efficiency of a population-based mass tuberculosis screening intervention among persons with diabetes in Jiangsu Province, China.
    Clin Infect Dis. 2023 Mar 3:ciad118. doi: 10.1093.
    >> Share

    December 2022
  204. DAVIS AG, Wasserman S, Stek C, Maxebengula M, et al
    A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis (The LASER-TBM Trial).
    Clin Infect Dis. 2022 Dec 9:ciac932. doi: 10.1093.
    >> Share

    October 2022
  205. DAVIS AG, Dreyer AJ, Albertyn C, Maxebengula M, et al
    Cognitive Impairment in Tuberculous Meningitis.
    Clin Infect Dis. 2022 Oct 20. pii: 6763738. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016